Kyverna Therapeutics is on the cusp of a historic first: getting a CAR-T therapy approved for an autoimmune disease—and now ...

A revolutionary cancer treatment is now being applied to a wide range of autoimmune disorders. Columnist Michael Le Page ...

According to the Autoimmune Association, approximately 50 million Americans live with an autoimmune disease, yet these ...

UCB has struck a deal to acquire Candid Therapeutics for $2 billion upfront, hijacking a planned reverse merger with Rallybio ...

The buyout involves a portfolio of antibody drugs Candid licensed from China-based biotechs and that UCB sees as part of the ...

These findings are important because they suggest that more selective JAK inhibition, particularly targeting JAK1 or JAK2, can effectively reduce organ pathology and pathogenic IFN-γ-producing immune ...

About 8% of people in the United States live with an autoimmune disease, a condition in which the immune system mistakenly ...

In 2021, a woman with severe lupus at University Hospital Erlangen in Germany became the first person to receive CAR-T cell ...

Women with autoimmune hepatitis appear more likely to develop cervical dysplasia and HPV infection than those without the ...

To have a drug that has an impact on mortality, it’s of huge interest and a benefit for patients with ILD,’ said rheumatologist Voon Ong, MBBS, PhD, who was not involved in the study.

You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. But autoimmune disease hair loss can also happen. Your immune system is meant to keep you healthy ...

From cutting-edge CAR‑T cell therapies resetting faulty immune systems to first‑in‑class drugs that calm inflammation without weakening defenses, 2026 is a landmark year for autoimmune disease ...